| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥12.25B | -11.5% |
| Gross profit | ¥0.75B | — |
| Operating income | ¥-1.80B | — |
| Net income | ¥-1.39B | — |
| Gross margin | 6.2% | Net margin -11.3% |
| Revenue Q/Q | -30.0% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥11.49B | 93.8% |
| R&D | ¥0.22B | 1.8% |
| SG&A | ¥0.81B | 6.6% |
| Tax & other | ¥-0.41B | -3.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
寒武纪 ・ 联影医疗 ・ 大全能源 ・ 华润微 ・ 阿特斯 ・ 百利天恒 ・ 芯原股份 ・ 中芯国际 ・ 特锐德 ・ 神州泰岳 ・ 乐普医疗 ・ 南风股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies